Detection of a putative HLA-A2,31012 processed (intronless) pseudogene in a laryngeal squamous cell carcinoma

Genes Chromosomes and Cancer

Volumn 27, Issue 1, 2000, Pages 26-34

  Feenstra, Manita ^a   Bakema, Jantine ^a   Verdaasdonk, Marina ^a   Rozemuller, Erik ^a   Van Den Tweel, Jan ^a   Slootweg, Pieter ^a   De Weger, Roel ^a   Tilanus, Marcel ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; MONOCLONAL ANTIBODY;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; CELL DIFFERENTIATION; DNA FLANKING REGION; DOWN REGULATION; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRON; LARYNX CARCINOMA; PRIORITY JOURNAL; PSEUDOGENE; RESTRICTION MAPPING; SQUAMOUS CELL CARCINOMA;

3' UNTRANSLATED REGIONS; ALLELES; ATP-BINDING CASSETTE TRANSPORTERS; BETA 2-MICROGLOBULIN; CARCINOMA, SQUAMOUS CELL; GENE AMPLIFICATION; GENES, MHC CLASS I; HISTOCOMPATIBILITY TESTING; HLA-A ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INTRONS; LARYNGEAL NEOPLASMS; PSEUDOGENES; SEQUENCE ANALYSIS, DNA;

EID: 0033991343     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(200001)27:1<26::AID-GCC4>3.0.CO;2-X     Document Type: Article

References (26)

1. Antoine M, Niessing J. 1984. Intron-less globin genes in the insect Chironomus thummi thummi. Nature 310:795-798.
2. Cabrera T, Collado A, Fernandez MA, Ferron A, Sancho J, Ruiz-Cabello F, Garrido F. 1998. High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens 52:114-123.
3. Dhawan P, Yang, E, Kumar A, Mehta KD. 1998. Genetic complexity of the human geranylgeranyltransferase Iβ-subunit gene: a multigene family of pseudogenes derived from mis-spliced transcripts. Gene 210:9-15.
4. Dhellin O, Maestre J, Heidmann T. 1997. Functional differences between the human LINE retrotransposon and retroviral reverse transcriptases for in vivo mRNA reverse transcription. EMBO J 16:6590-6602.
5. Feenstra M, Rozemuller E, Duran K, Stuy I, van den Tweel J, Slootweg P, de Weger R, Tilanus M. 1999a. Mutations in the β2m gene is not a frequent event in head and neck squamous cell carcinomas. Hum Immunol 60:697-706.
6. Feenstra M, Veltkamp M, van Kuik J, Wiertsema S, Slootweg P, van den Tweel J, de Weger R, Tilanus M. 1999b. HLA class I expression and chromosomal deletions at 6p and 15q in head and neck squamous cell carcinomas. Tissue Antigens 54:235-245.
7. Garrido F, Cabrera T, Lopez-Nevot MA, Ruiz-Cabello F. 1995. HLA class I antigens in human tumors. Adv Cancer Res 67:155-195.
8. Garrido F, Ruiz-Cabello F, Cabrera T, Perez-Villar JJ, Lopez-Botet M, Duggan-Keen M, Stern P. 1997. Implications for immunosurveillance of altered HLA class I phenotypes in human tumors. Immunol Today 18:89-95.
9. Geraghty DE, Koller BH, Hansen JA, Orr HT. 1992. The HLA class I family includes at least six genes and twelve pseudogenes and gene fragments. J Immunol 149:1934-1946.
10. Glynne R, Powis SH, Beck S, Kelly A, Kerr L-A, Trowsdale J. 1991. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 353:355-357.
11. Kambhu S, Falldorf P, Lee JS. 1990. Endogenous retroviral long terminal repeats within the HLA-DQ locus. Proc Natl Acad Sci USA 87:4927-4931.
12. Kleijmeer MJ, Kelly A, Geuze HJ, Slot JW, Townsend A, Trowsdale J. 1992. Location of MHC-encoded transporters in the endoplasmatic reticulum and cis-Golgi. Nature 357:342-344.
13. Koopman LA, Mulder A, Corver WE, Anholts JDH, Giphart MJ, Claas FHJ, Fleuren GJ. 1998. HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines. Tissue Antigens 51:623-636.
14. Löwer R, Löwer J, Kuth R. 1996. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93:5177-5184.
15. McCarrey JR, Thomas K. 1987. Human testis-specific PGK gene lacks introns and posseses characteristics of a processed gene. Nature 326:501-505.
16. Miller SA, Dykes DD, Polesky HF. 1998. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215-1217.
17. Moos M, Gallwitz D. 1982. Structure of a human β-actin-related pseudogene which lacks intervening sequences. Nucl Acids Res 10:7843-7849.
18. Palmer E, Cresswell P. 1998. Mechanisms of MHC class I-restricted antigen processing. Ann Rev Immunol 16:323-358.
19. Patience C, Wilkinson DA, Weiss RA. 1997. Our retroviral heritage. Trends Genet 13:116-120.
20. Rogers JH. 1986. The origin and evolution of retroposons. Int Rev Cytol 93:187-279.
21. Scheltinga SA, Johnston-Dow LA, White CB, van der Zwan A-W, Bakema JE, Rozemuller EH, van den Tweel JG, Kronick MN, Tilanus MGJ. 1997. A generic sequencing based typing approach for the identification of HLA-A diversity. Hum Immunol 57:120-128.
22. Stam NJ, Vroom ThM, Peters OJ, Pastoors EB, Ploegh HL. 1990. HLA-A and HLA-B - specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electronmicroscopy. Int Immunol 2:113-125.
23. Townsend A, Bodmer H. 1989. Antigen recognition by class I restricted T lymphocytes. Annu Rev Immunol 7:601-624.
24. Vanin E. 1984. Processed pseudogenes: characteristics and evolution. Biochim Biophys Acta 782:231-241.
25. Wei ML, Cresswell P. 1992. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature 356:443-446.
26. Zinkernagel RM, Doherty PC. 1997. The discovery of MHC restriction. Immunol Today 18:14-17.